For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...
In children aged 5 to 15 years with mild asthma, budesonide-formoterol reliever monotherapy is superior to salbutamol for ...
Please provide your email address to receive an email when new articles are posted on . BATURA showed a 47% reduction in severe exacerbation risk with albuterol budesonide vs. albuterol in patients ...
The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual ...
In a recent interview with Fox News, HHS Secretary Robert F. Kennedy, Jr. highlighted the work of two local physicians treating patients in the Texas measles outbreak -- Richard Bartlett, MD, and Ben ...
The US Food and Drug Administration (FDA) has approved budesonide oral suspension (Eohilia, Takeda), the first oral treatment for eosinophilic esophagitis (EoE). Budesonide oral suspension is a ...
Patients with eosinophilic oesophagitis (EoE) unresponsive to off-label swallowed topical corticosteroids (STCs) demonstrated a positive response to an oesophageal-targeted budesonide formulation.
The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings. They ...